FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> GlaxoSmithKline | Ireland

GSK ops review has Irish officials worried

Tools

GlaxoSmithKline (NYSE: GSK) is reviewing its Irish manufacturing operations, planning to finalize a restructuring proposal by autumn. And local officials fear the company will eliminate "hundreds" of jobs. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about GlaxoSmithKline   Ireland